Tag: Rosiglitazone & Metformin [Avandamet]

By Posted on Posted in Adverse Drug Reaction [ADR], Market Restriction Tagged with , , , , ,

September 23, 2010 – We present here a very significant announcement by the American Food and Drug Administration (FDA) in its original. Please note that the European Medicines Agency (EMEA) also today recommended the suspension of the marketing authorisations for …

FDA Significantly Restricts Access to the Diabetes Drug Rosiglitazone [Avandia] Read more »

By Posted on Posted in Adverse Drug Reaction [ADR] Tagged with , , ,

July 15, 2010 – In the light of recently published scientific studies and an upcoming U.S. Food and Drug Administration (FDA) Advisory Committee meeting examining the heart-related (cardiovascular) safety of the diabetes drug rosiglitazone, Health Canada is informing health care …

Health Canada: Status of Rosiglitazone Drugs [Avandia, Avandamet, and Avandaryl] in Canada Read more »